<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04949828</url>
  </required_header>
  <id_info>
    <org_study_id>P20-238</org_study_id>
    <nct_id>NCT04949828</nct_id>
  </id_info>
  <brief_title>Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms</brief_title>
  <acronym>CisCP</acronym>
  <official_title>Observational Study Assessing for Effect of CREON on Symptoms of Exocrine Pancreatic Insufficiency (EPI) in Patients With EPI Due to Chronic Pancreatitis (CP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AbbVie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exocrine Pancreatic Insufficiency (EPI) is a condition where pancreatic enzyme quantity or&#xD;
      activity is reduced below threshold needed for normal digestion. Symptoms include bloating,&#xD;
      flatulence, diarrhea and steatorrhea. This is an observational study assessing for effect of&#xD;
      CREON on symptoms of EPI in participants with EPI due to chronic pancreatitis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Score of EPI Symptoms Domain Using an EPI Patient-Reported Outcomes Questionnaire</measure>
    <time_frame>Up to 1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in T-scores for Patient-Reported Outcomes Measurement and Information System(PROMIS) Questionnaires for Anxiety, Depression, and Fatigue</measure>
    <time_frame>Up to 1 month</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Chronic Pancreatitis</condition>
  <arm_group>
    <arm_group_label>Participants on CREON</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CREON</intervention_name>
    <description>Oral Capsules</description>
    <arm_group_label>Participants on CREON</arm_group_label>
    <other_name>pancrelipase</other_name>
    <other_name>ABT-SLV245</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult participants with medical diagnosis of chronic pancreatitis (CP) and exocrine&#xD;
        pancreatic insufficiency (EPI)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Medical history of chronic pancreatitis (CP).&#xD;
&#xD;
          -  Diagnosis of Exocrine Pancreatic Insufficiency (EPI).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of cystic fibrosis, pancreatic cancer, pancreatic surgery, gastric bypass&#xD;
             surgery, extensive bowel surgery, inflammatory bowel disease, celiac disease,&#xD;
             irritable bowel syndrome&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ABBVIE INC.</last_name>
    <role>Study Director</role>
    <affiliation>AbbVie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diala Harb</last_name>
    <phone>+1 847-938-0925</phone>
    <email>diala.harb@abbvie.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University School of Med /ID# 229530</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305-2200</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Florida - Archer /ID# 227057</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>John Hopkins University /ID# 227061</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287-0020</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Minnesota - Minneapolis /ID# 227364</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455-0341</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>NYU Langone Health /ID# 230818</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016-2708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Duke University Hospital /ID# 227065</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center /ID# 227844</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210-1267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine - Baylor Medical Center /ID# 227067</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030-3411</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.rxabbvie.com/</url>
    <description>Related info</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 21, 2021</study_first_submitted>
  <study_first_submitted_qc>July 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic pancreatitis</keyword>
  <keyword>Exocrine Pancreatic Insufficiency</keyword>
  <keyword>CREON</keyword>
  <keyword>pancrelipase</keyword>
  <keyword>ABT-SLV245</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
    <mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancrelipase</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

